Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14

Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14

Abstract Background Heart failure (HF) is a common cardiovascular complication of type 2 diabetes (T2D). This secondary analysis investigated baseline factors and treatment differences associated with risk of hospitalization for HF (hHF), and the possible association between severe hypoglycemia and...

Full description

Bibliographic Details
Main Authors: Richard E. Pratley, Mansoor Husain, Ildiko Lingvay, Thomas R. Pieber, Thomas Mark, Hans A. Saevereid, Daniel Vega Møller, Bernard Zinman, the DEVOTE Study Group
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Cardiovascular Diabetology
Subjects:
Clinical trial
Hospitalization for heart failure
Severe hypoglycemia
Insulin degludec
Type 2 diabetes
Online Access:http://link.springer.com/article/10.1186/s12933-019-0960-8

Internet

http://link.springer.com/article/10.1186/s12933-019-0960-8

Similar Items